National network specialized in pathology and care of bone sarcomas


L’ANSM suspend les essais masitinib promus par AB Science. Le GSF-GETO recommande imatinib ou sunitinib en remplacement.

Account request: user information
  • 1- User information
  • 2- Chart agreement
  • 3- Confirmation
  • 4- Completed
Username is required, size must be between 3 and 20 characters, allowed characters are : small letters (no accents), numbers, '.' and '-'